CELG Headlines | Celgene Corporation Stock - Yahoo! Finance

Tue, May 21, 2013, 11:06PM EDT - U.S. Markets closed

Dow

0.34% Nasdaq

0.16%

More On CELG

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

Celgene Corporation (CELG)

-NasdaqGS

123.50 0.38(0.31%) 4:00PM EDT|After Hours : 123.44 0.06 (0.05%) 4:30PM EDT

Add to Portfolio

Headlines

Get Headlines for:

Wednesday, March 6, 2013

Stocks Turn Up After Fed Report; Celgene Hit New Highat Investor's Business Daily (Wed, Mar 6)

Tuesday, March 5, 2013

2 Biotech Superstars For 2013at Seeking Alpha (Tue, Mar 5)
[video] Stocks, Sentiment Soarat CNBC (Tue, Mar 5)
Celgene's CEO Presents at Cowen & Company 33rd Annual Health Care Conference (Transcript)at Seeking Alpha (Tue, Mar 5)
Celgene's CEO Presents at Cowen & Company 33rd Annual Health Care Conference (Transcript)Seeking Alpha (Tue, Mar 5)
[video] NASDAQ Versus Dow All-Time HIghsat CNBC (Tue, Mar 5)

Monday, March 4, 2013

Celgene Trial Disappointment No Disasterat Motley Fool (Mon, Mar 4)
Pluristem & UTHR Progress with PLX-PADZacks (Mon, Mar 4)
Stocks End Higher, Dow Within 50 Points of All-Time High, GOOG Gainsat CNBC (Mon, Mar 4)
2 Sides of Celgene's Apremilast Resultsat Motley Fool (Mon, Mar 4)
Celgene's Apremilast EncouragesZacks (Mon, Mar 4)
[video] Halftime Pops & Dropsat CNBC (Mon, Mar 4)
Gilead Sciences Will Likely Beat Revenue Consensus and 3 Analyst Notes Making Wavesat Wall St. Cheat Sheet (Mon, Mar 4)
Celgene Stock Drops After Psoriasis Drug Disappointsat Investor's Business Daily (Mon, Mar 4)
BRIEF-Celgene down in premarket after psoriasis drug trial resultsat Reuters (Mon, Mar 4)
US Shares Seen Lower as China Curbs Property Marketat CNBC (Mon, Mar 4)
Early Movers: RIG, LVS, YHOO & Moreat CNBC (Mon, Mar 4)
Celgene: Phenomenal Guidance For This Bio Stockat Seeking Alpha (Mon, Mar 4)
Threshold Pharmaceuticals: A Biotech Trading At Half Its Intrinsic Valueat Seeking Alpha (Mon, Mar 4)

Saturday, March 2, 2013

[$$] Celgene Drug Results Fall Short of Earlier Trialat The Wall Street Journal (Sat, Mar 2)
Celgene Psoriasis Drug Helped Third of Patients in Studyat Bloomberg (Sat, Mar 2)
Oral Apremilast Achieves Statistical Significance for the Primary Endpoint of PASI-75 in the First Phase III Study (ESTEEM 1) in Patients with PsoriasisBusiness Wire (Sat, Mar 2)
Celgene drug shown to be effective, safe in psoriasis trialat Reuters (Sat, Mar 2)

Friday, March 1, 2013

Immunomedics Has A Cheap, Deep And Recently Capitalized Pipelineat Seeking Alpha (Fri, Mar 1)
3 Stocks With Strong Buybacks And How To Invest: TJX, Texas Instruments, And Celgeneat Seeking Alpha (Fri, Mar 1)

Older Headlines - Most Recent Headlines

Add CELG News to My Yahoo!

Copyright © 2009 Yahoo! All rights reserved.

Quotes are real-time for NASDAQ, NYSE, and NYSE MKT. See also delay times for other exchanges. All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein. Real-Time continuous streaming quotes are available through our premium service. You may turn streaming quotes on or off.

Fundamental company data provided by Capital IQ. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). International historical chart data, daily updates, fund summary, fund performance, dividend data and Morningstar Index data provided by Morningstar, Inc.